Life Satisfaction Among Cancer Survivors With and Without Smell and Taste Dysfunction: Evidence from the National Health Interview Survey
Esparza, V.; Ramirez, V. A.; Nolden, A.; Stromberg, K.; Parma, V.
Show abstract
BackgroundChemosensory dysfunction is a common symptom experienced by cancer patients. Albeit common, these symptoms lack guidelines for management and are rarely addressed by healthcare providers, and therefore, how taste and smell dysfunctions affect quality of life in cancer patients is understudied. MethodsTo address this gap, we analyzed data from the 2021 National Health Interview Survey (NHIS) to assess associations between smell and taste dysfunction and life satisfaction among adults who self-reported cancer (N = 3,327; age range:18- 85+ years; 57% F; 85% Non-Hispanic white). Participants reported whether they experienced difficulty tasting, difficulty smelling, and whether they were satisfied with life (binary) in the past 12 months. ResultsAmong respondents, 14% reported taste dysfunction (N = 456) and 22% reported smell dysfunction (N = 736), and 10.1% reported both smell and taste dysfunction (N = 340). After adjusting for age and sex, a logistic regression revealed that cancer patients reporting difficulty tasting had 60% lower odds of reporting life satisfaction compared to those who did not report difficulty tasting (OR = 0.39, p<0.0001, CI [.27.58]). Similarly, cancer patients reporting difficulty smelling had 40% lower odds of reporting life satisfaction compared to those who did not report trouble smelling (OR = 0.60, p=0.006, CI [.42.86]). Considering that the prevalence of chemosensory dysfunction is often underestimated when measured with self-reports, these findings likely represent a conservative estimate of the impact on subjective wellbeing in cancer. ConclusionThese results underscore the relevance of assessing chemosensory symptoms in cancer populations. Routine evaluation of smell and taste loss may offer a valuable opportunity to improve quality of life and guide supportive care.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Molecular signatures for inflammation vary across cancer types and correlate significantly with tumor stage, gender and vital status of patients 91%
- Do people with disabilities experience disparities in cancer care? A systematic review 91%
- Life expectancy, quality of life, and hope among Japanese patients receiving home medical care 91%
Similar papers in this journal
- Impact of a natural disaster on access to care and biopsychosocial outcomes among Hispanic/Latino cancer survivors 92%
- Disparities in outcomes among patients diagnosed with cancer associated with emergency department visits 92%
- Pan-cancer analyses of the associations between 109 pre-existing conditions and cancer treatment patterns across 19 adult cancers 91%
Similar papers in this journal
- Exploring Patient Centered Perspectives on Suicidal Ideation: A Mixed Methods Investigation in Gastrointestinal Cancer Care 91%
- Effect of a novel food rich in miraculin on the oral microbiome of malnourished oncologic patients with dysgeusia 90%
- Ethnicity-Specific Molecular Alterations in MAPK and JAK/STAT Pathways in Early-Onset Colorectal Cancer 89%
Similar papers in this journal
- Establishment and validation of pre-therapy cervical vertebrae muscle quantification as a prognostic marker of sarcopenia in head and neck patients receiving definitive cancer surgery 90%
- A pro-oxidant combination of resveratrol and copper down-regulates hallmarks of cancer and immune checkpoints in patients with advanced oral cancer: Results of an exploratory study (RESCU 004) 89%
- Factors affecting COVID-19 outcomes in cancer patients - A first report from Guys Cancer Centre in London 89%
Similar papers in this journal
- Detecting PI3K and TP53 Pathway Disruptions in Early-Onset Colorectal Cancer Among Hispanic/Latino Patients 90%
- Associations of the 2018 World Cancer Research Fund/American Institute of Cancer Research (WCRF/AICR) Cancer Prevention Recommendations with Stages of Colorectal Carcinogenesis 89%
- Sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors on new-onset overall cancer in type 2 diabetes mellitus: a population-based study 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.